Skip to content
TrackPodcasts
scienceFeb 8, 202416:07pending

Why are we still waiting for a male contraceptive pill?

Science Weekly

About this episode

Despite research into a male contraceptive pill starting around the same time as its female counterpart, no product has ever made it to market. But that could soon change, with a new non-hormonal male pill entering human trials in the UK late last year. Ian Sample speaks to bioethicist Prof Lisa Campo-Engelstein of the University of Texas and Prof Chris Barratt from the University of Dundee about why male contraceptives have been so difficult to develop, and what kind of options are in the pipeline. Help support our independent journalism at theguardian.com/sciencepod

Get every episode summarized

Each time Science Weekly publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.

Email me new episodes

Free for 3 shows. No card needed.

No transcript yet

This episode has not been transcribed. Request it and it moves to the front of the queue.

Why are we still waiting for a male contraceptive pill?

Science Weekly

0:00
16:07

More episodes

More from Science Weekly

View all episodes →